© 2020 MJH Life Sciences, Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Author | Duke Leahey
Articles
Nuogen Pharma: Innovation in the fight against itch
March 30, 2020
Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.